Literature DB >> 8879088

The safety of fluoxetine during pregnancy and lactation.

I Nulman1, G Koren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879088     DOI: 10.1002/(SICI)1096-9926(199605)53:5<304::AID-TERA4>3.0.CO;2-0

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


× No keyword cloud information.
  6 in total

Review 1.  Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.

Authors:  P Mourilhe; P E Stokes
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

2.  Distribution and excretion of fluoxetine and norfluoxetine in human milk.

Authors:  J H Kristensen; K F Ilett; L P Hackett; P Yapp; M Paech; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 3.  SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Postpartum psychiatric disorders : guidelines for management.

Authors:  A Buist
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 5.  Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review.

Authors:  Giovanni Previti; Susan Pawlby; Sahmina Chowdhury; Eugenio Aguglia; Carmine M Pariante
Journal:  Arch Womens Ment Health       Date:  2014-09-12       Impact factor: 3.633

Review 6.  Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges.

Authors:  Richard A Epstein; Katherine M Moore; William V Bobo
Journal:  Drug Healthc Patient Saf       Date:  2014-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.